No abstract available
MeSH terms
-
Animals
-
Antineoplastic Agents / therapeutic use
-
DNA-Binding Proteins / genetics
-
DNA-Binding Proteins / metabolism*
-
Gene Expression Regulation, Leukemic
-
Hematopoiesis* / genetics
-
Hematopoietic Stem Cells / metabolism*
-
Hematopoietic Stem Cells / pathology
-
Histone-Lysine N-Methyltransferase / genetics
-
Histone-Lysine N-Methyltransferase / metabolism*
-
Humans
-
Leukemia / drug therapy
-
Leukemia / genetics
-
Leukemia / metabolism*
-
Molecular Targeted Therapy
-
Myeloid-Lymphoid Leukemia Protein / genetics
-
Myeloid-Lymphoid Leukemia Protein / metabolism*
-
Neoplastic Stem Cells / drug effects
-
Neoplastic Stem Cells / metabolism*
-
Neoplastic Stem Cells / pathology
-
Signal Transduction
-
Transcription Factors / genetics
-
Transcription Factors / metabolism*
Substances
-
Antineoplastic Agents
-
DNA-Binding Proteins
-
KMT2A protein, human
-
Transcription Factors
-
Myeloid-Lymphoid Leukemia Protein
-
ASH1L protein, human
-
Histone-Lysine N-Methyltransferase